Skip to main content
. 2020 Sep 22;7(1):e000701. doi: 10.1136/bmjresp-2020-000701

Table 2.

Details of treatment decisions

Treatment decision Patients
Diagnostic only—not fit for SACT 7 (15.6%)
SACT options not suitable for patient 12 (26.7%)
Immunotherapy or hormonal therapy initiated 9 (20.0%)
Chemotherapy initiated 13 (28.9%)
SACT altered in response to results 1 (2.2%)
Patient refused treatment 3 (6.6%)

SACT, systemic anti cancer treatment.